Status:
RECRUITING
Advanced Goal-Directed Impedancemetry Strategy for Lung Resection Surgery
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
High-risk Lung Resection Surgery
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
High-risk patients scheduled for lung resection surgery are increasing and theoretically eligible to perioperative individualized goal-directed fluid therapy (GDFT). However, thoracic surgery is chall...
Eligibility Criteria
Inclusion
- Adults (≥ 18 years old)
- High-risk patients (ASA score ≥ 3 and/or ventilatory deficit (defined as FEV1≤70% and/or VC≤70%) and/or AKI risk index ≥ III and/or modified clinical Lee Criteria ≥2) undergoing elective open-chest or video-assisted or robotic lung resection surgery
- Patients who have provided written informed consent to participate in the study
- Patients affiliated with a social health insurance
Exclusion
- Pleural or mediastinal resection surgery
- Emergency surgery (Less than 24h)
- Patients unable to understand the purpose of the study
- Patients participating in another trial that would interfere with this study
- Female patients who are pregnant, lactating or women of child-bearing potential without effective methods of contraception
- Female patients with positive β-HCG blood test
- Patients under judicial protection (guardianship, curatorship)
Key Trial Info
Start Date :
December 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
722 Patients enrolled
Trial Details
Trial ID
NCT06156943
Start Date
December 12 2024
End Date
January 1 2027
Last Update
December 24 2024
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Louis Pradel
Bron, France, 69500
2
CHU Dijon Bourgogne
Dijon, France, 21000
3
Hôpital Arnaud de Villeneuve - CHU Montpellier
Montpellier, France, 34090
4
Chu Nancy
Nancy, France